Law360, New York (June 29, 2012, 7:29 PM ET) -- Manufacturers of artificial joints, synthetic heart valves and other sophisticated medical devices say they'll continue fighting an industry tax contained in the U.S. Supreme Court-approved health care reform law, but their odds of success look increasingly slim, experts said Friday.
At issue is a 2.3 percent excise tax that would take effect Jan. 1 and raise $29 billion over the next decade — money seen as vital to funding expanded coverage in the Patient Protection and Affordable Care Act. After the high court gave its blessing...
Device Cos. Face Slim Chance Of Tax Repeal After ACA Ruling
To view the full article, take a free trial now.
